220028-09-1

Basic information

• Product Name: NU₂₀₁₇
• Synonyms: NU₂₀₁₇
• CAS NO: 220028-09-1
• Molecular Weight: 232.285
• Mol File: 220028-09-1.mol

Chemical Properties

• CAS DataBase Reference: NU₂₀₁₇(CAS DataBase Reference)
• NIST Chemistry Reference: NU₂₀₁₇(220028-09-1)
• EPA Substance Registry System: NU₂₀₁₇(220028-09-1)

Safety Data

• Hazardous Substances Data: 220028-09-1(Hazardous Substances Data)

Upstream product

• 87-42-3 6-chloropurine 
• 100-49-2 cyclohexylmethyl alcohol 

Downstream Products

• 1020397-80-1 C₂₁H₂₄N₄O₃ 
• 1020397-64-1 C₂₁H₂₄N₄O₃ 

Relevant articles and documents

Identification of novel purine and pyrimidine cyclin-dependent kinase inhibitors with distinct molecular interactions and tumor cell growth inhibition profiles

Substituted guanines and pyrimidines were tested as inhibitors of cyclin B1/CDK1 and cyclin A3/CDK2 and soaked into crystals of monomeric CDK2. O6- Cyclohexylmethylguanine (NU2058) was a competitive inhibitor of CDK1 and CDK2 with respect to ATP (K(i) values: CDK1, 5 ± 1 μM; CDK2, 12 ± 3 μM) and formed a triplet of hydrogen bonds (i.e., NH-9 to Glu 81, N-3 to Leu 83, and 2-NH2 to Leu 83). The triplet of hydrogen bonding and CDK inhibition was reproduced by 2,6-diamino-4-cyclohexylmethyloxy-5-nitrosopyrimidine (NU6027, K(i) values: CDK1, 2.5 ± 0.4 μM; CDK2, 1.3 ± 0.2 μM). Against human tumor cells, NU2058 and NU6027 were growth inhibitory in vitro (mean GI50 values of 13 ± 7 μM and 10 ± 6 μM, respectively), with a pattern of sensitivity distinct from flavopiridol and olomoucine. These CDK inhibition and chemosensitivity data indicate that the distinct mode of binding of NU2058 and NU6027 has direct consequences for enzyme and cell growth inhibition.

6-Oxo and 6-thio purine analogs as antimycobacterial agents

6-Oxo and 6-thio analogs of purine were prepared based on the initial activity screening of a small, diverse purine library against Mycobacterium tuberculosis (Mtb). Certain 6-oxo and 6-thio-substituted purine analogs described herein showed moderate to good inhibitory activity. N 9-substitution apparently enhances the anti-mycobacterial activity in the purine series described herein. Several 2-amino and 2-chloro purine analogs were also synthesized that showed moderate inhibitory activity against Mtb.